VertiGreens Investigating the Effects of Iron Biofortification of Microgreens on Iron Status in Women
Launched by UNIVERSITY OF ABERDEEN · May 14, 2025
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called VertiGreens, is exploring how eating iron-rich microgreens can improve iron levels in women. The study will involve healthy women of reproductive age (between 18 and 49 years old) and postmenopausal women who haven't had their period for a year. Participants will receive smoothie kits containing these special microgreens for 28 days, and researchers will measure how this affects their iron levels and overall health. They will also look at participants' usual diets, physical activity, and any gastrointestinal issues they may have.
To be eligible for the study, women must be healthy and not taking certain medications, like iron or vitamin B12 supplements. Some health conditions, such as recent anemia, food allergies, or diabetes, may also prevent someone from participating. The trial is currently not recruiting participants, but it will provide valuable insights into how improving diets through innovative farming methods can support women's health. If you are interested, keep an eye out for when the study starts recruiting!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy females
- • 15 of reproductive age (18-49)
- • 15 postmenopausal (not had their period for an entire year)
- Exclusion Criteria:
- Medication exclusion criteria:
- • Supplementing iron or vitamin B12
- • Smoking or vaping
- • Taking anticoagulant medication (blood thinners) except for Aspirin 75mg
- Medical exclusion criteria:
- • Anyone who is planning to be pregnant, is pregnant or breastfeeding
- • Anyone with iron or vitamin B12 deficiency anaemia
- • Anyone with history of anaemia in the past 3 months that required treatment
- • Anyone who has Hb \<120 g/L (12 g/dL) at screening
- • Anyone with food allergies, self-reported food sensitivity or intolerance
- • Anyone with coeliac disease or gluten intolerance
- • Anyone suffering from a psychiatric disorder or any type of substance abuse
- • Anyone with Type 1 diabetes and Type 2 diabetes
- • Anyone suffering from unregulated thyroid disease
- • Anyone with gastrointestinal conditions or bariatric surgery
- • Anyone with haematological conditions including Thrombocytopaenia and Sickle cell anaemia
- Other exclusion criteria:
- • Anyone with unsuitable veins for blood sampling
- • Anyone who donated blood in the last 16 weeks
- • Anyone who is unable to fluently speak, read and understand English
About University Of Aberdeen
The University of Aberdeen, a prestigious institution founded in 1495, is a leading center for research and education in healthcare and clinical sciences. With a commitment to advancing knowledge and improving patient outcomes, the university actively sponsors clinical trials that explore innovative treatments and therapies across various medical fields. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the University of Aberdeen fosters collaborations with healthcare professionals and industry partners to enhance the quality of clinical research and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aberdeen, , United Kingdom
Patients applied
Trial Officials
Alexandra Johnstone, Prof
Principal Investigator
University of Aberdeen, Rowett Institute of Nutrition and Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported